国信证券发布药明康德研报：TIDES业务高速增长，2025年二季度增长提速

Core Viewpoint - Guosen Securities has given WuXi AppTec (603259.SH, latest price: 98.85 CNY) an "outperform" rating due to strong order growth and an upward revision of the annual performance guidance [2] Group 1: Company Performance - The company has experienced robust order growth, prompting a proactive adjustment of its annual performance guidance [2] - In the chemical business, the small molecule CRDMO has shown efficient transformation, while the TIDES business has made significant contributions [2] - The testing and biological services segment has maintained a steady performance [2] Group 2: Market Dynamics - The company has deepened its global customer structure, with the U.S. market continuing to show leading growth rates [2]